Stacey Bowlin Joins Georgia Bio as Senior Vice President of Industry Engagement and Marketing

Georgia Bio, the state’s life science trade association, announced today the appointment of Stacey Bowlin as the organization’s Senior Vice President of Industry Engagement and Marketing. Bowlin will collaborate closely with Georgia Bio’s CEO on the company's strategic priorities, including the company’s go-to-market positioning and its integrated work with members.

 

“Stacey is an association brand strategist who will help both our members and GA Bio harness change to maximize performance and connectivity with key stakeholders across the state. She’ll be invaluable in driving our company’s strategic initiatives forward as we continue to evolve and grow," said Georgia Bio CEO Maria Thacker Goethe. “We’re very pleased to welcome Stacey to the organization.”

 

Over the course of her career, Bowlin has worked for a range of service organizations delivering marketing and event solutions to drive growth, retention, and revenue. Most recently, Bowlin worked at California Life Sciences, where she served as the association's Senior Vice President of Marketing and Industry Engagement. At CLS, she built a marketing function that included the organization’s communications and profile building efforts, events portfolio, sponsorship and other non-dues revenue initiatives. Stacey also oversaw CLS’ entrepreneurship programs, with an emphasis on expanding opportunities for startup companies, including CLS’s acclaimed FAST advisory program, and new initiatives that support the innovation pipeline. 

 

Previously, she spent more than a decade at the Biotechnology Innovation Organization (BIO), the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. 

 

"I am excited to work with the GA Bio team to amplify their portfolio of programs, events, and initiatives, helping our members advance critical products and services that will transform patient’s lives,” said Stacey Bowlin. “Together, we will continue to focus on the needs of our members.”

 

Georgia Bio also recently welcomed Katie Rogers to the organization. In her role as Director of Innovation & Entrepreneurship, Katie will focus on entrepreneurship initiatives connecting life science startups to resources needed to help them scale their ventures. She will also serve as the liaison for many of Georgia Bio’s committees and networks to ensure strong partnerships.

 

About Georgia Bio


Georgia Bio (GaBio) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, GaBio has served its members by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. GaBio also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. GaBio works to shape public policy, improve access to breakthrough technologies, educate lawmakers, provide member programs, strengthens the workforce pipeline, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. For more information, visit www.gabio.org | www.georgiabioed.org


MEDIA CONTACT:

Melissa Carter

404-920-2043

mcarter@gabio.org

By Maria Thacker Goethe April 18, 2025
The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.
By Sheran Brown April 10, 2025
Georgia Life Sciences Selects Fulton County Schools Innovation Academy Student as the 2025 Georgia BioGENEius Winner Sandy Springs & Rockmart Teens Take Top Honors in Statewide Science Competition Atlanta, GA (April 4, 2025) – Georgia Life Sciences today named Bhavya Alapati , a junior at Fulton County Schools Innovation Academy, as the winner of the 2025 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. Eleven students from across Georgia competed for this year’s title and cash prize. Bhavya’s project investigated a novel method of identifying strokes using a device she created called SpectroStroke, a small-scale spectrophotometer, to detect homocysteine, an amino acid product that is associated with stroke. Bhavya identified the ability of homocysteine to be detected using Ellman’s reagent, which reacts with the free sulfhydryl group on the molecule to produce a yellow color. Bhavya created a wearable patch that contains the Ellman’s reagent. Then, she designed the SpectroStroke to be able to detect the color change when the patch is exposed to elevated levels of homocysteine. Bhavya’s SpectroStroke can detect normal levels of homocysteine up to extremely high levels seen in those experiencing a stroke. The ability to detect a stroke earlier would reduce damage and long-term effects of the condition. A future iteration of the SpectroStroke would include real-time monitoring capabilities to help track changing homocysteine levels. "Supporting and celebrating outstanding research and innovation in biotechnology is vital for the future of science and medicine. The Georgia BioGENEius Challenge not only encourages the brightest young minds to explore their potential but also nurtures the next generation of leaders who will drive groundbreaking advancements in biotechnology,” said Georgia Life Sciences President and CEO Maria Thacker-Goethe. “By recognizing and empowering these students, we are helping to shape a future where innovation thrives and the possibilities for improving lives are endless. Well done, Bhavya!” Georgia Life Sciences also congratulates the Georgia BioGENEius runner-up, Shelby Kendrick , who is a senior at Paulding County High School in Dallas, GA. Shelby’s research investigated the ability of Aspergillus terreus, a fungus found in soil, to degrade pre-treated polypropylene plastic (PP). This fungus has been discovered to produce high concentrations of degrading enzymes and raises the moisture level of its substrate. Shelby isolated the fungus from soil samples and confirmed the species using PCR amplification and DNA barcoding. Samples of polypropylene were pre-treated with 75% ethanol and UV exposure, then placed in a liquid culture of A. terreus in Minimal Salt Medium (MSM) media, and the culture was incubated for 23 days. At the end of the trial period, PP samples were analyzed using Scanning Electron Microscopy. These samples showed changes in their surface layer, indicating evidence of biodegradation. Polypropylene plastic is found in household items such as plastic cups and is a known problem in the environment due to its inability to degrade. Shelby’s future research on the use of A. terreus for biodegradation includes optimizing degradation conditions and assessing methods of application in the environment. Judging the 2025 Georgia BioGENEius Challenge were Ralph L. Cordell, CDC, and Alex Harvey, ViaMune. Cash prizes were awarded to Bhavya and Shelby. # # # About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
By Maria Thacker Goethe April 9, 2025
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition
MORE POSTS